Tris(acetonitrile)pentamethylcyclopentadienylrhodium(III) hexafluoroantimonate, min. 98

Modify Date: 2024-01-01 23:17:09

Tris(acetonitrile)pentamethylcyclopentadienylrhodium(III) hexafluoroantimonate, min. 98 Structure
Tris(acetonitrile)pentamethylcyclopentadienylrhodium(III) hexafluoroantimonate, min. 98 structure
Common Name Tris(acetonitrile)pentamethylcyclopentadienylrhodium(III) hexafluoroantimonate, min. 98
CAS Number 59738-27-1 Molecular Weight 361.28700
Density N/A Boiling Point N/A
Molecular Formula C16H24N3Rh++ Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name [Rh(η5-pentamethylcyclopentadienyl)(acetonitrile)3](2+)
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C16H24N3Rh++
Molecular Weight 361.28700
Exact Mass 361.10300
PSA 71.37000
LogP 5.22914

 MSDS


Section 1: Product Identification
Chemical Name:Tris(acetonitrile)pentamethylcyclopentadienylrhodium(III) hexafluoroantimonate, min. 98%
CAS Registry Number:59738-27-1
Formula:C16H24F12N3RhSb2
EINECS Number:none
Chemical Family:organometallic complex
Synonym:none

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title compound59738-27-1100%0.5mg/m3 (as Sb)0.5mg/m3 (as Sb)

Section 3: Hazards Identification
Emergency Overview:Irritating to skin, eyes and respiratory tract.
Primary Routes of Exposure:Ingestion, inhalation, eyes
Eye Contact:Causes slight to mild irritation of the eyes.
Skin Contact:Causes slight to mild irritation of the skin.
Inhalation:Irritating to the nose, mucous membranes and respiratory tract.
Ingestion:No information available on the physiological effects of ingestion. May be harmful if swallowed.
Acute Health Affects:Irritating to skin, eyes and respiratory tract.
Chronic Health Affects:Prolonged exposure to hydrolysable fluorine compounds can cause deterioration of bone and tooth structure.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:no data
Autoignition Temperature:no data
Explosion Limits:no data
Extinguishing Medium:carbon dioxide, dry powder or foam
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire, this material may emit irritating fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:Small spills can be mixed with vermiculite or sodium carbonate and swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a tightly sealed container. Keep in a cool, dry, well-ventilated place.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves.
Ventilation:Handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:light yellow powder
Molecular Weight:832.79
Melting Point:no data
Boiling Point:no data
Vapor Pressure:no data
Specific Gravity:no data
Odor:none
Solubility in Water:insoluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:no hazardous polymerization
Incompatibility:oxidizing agents and halogens
Decomposition Products:carbon monoxide, carbon dioxide, organic fumes, metal oxides and fluorinated by-products

SECTION 11: Toxicological Information
RTECS Data:No information available in the RTECS files.
Carcinogenic Effects:no data
Mutagenic Effects:no data
Tetratogenic Effects:no data

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Not listed in the TSCA inventory
SARA (Title 313):See Category Code N010 for reporting
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Synonyms

tris(acetonitrile)pentamethylcyclopentadienylrhodium(iii) hexafluoroantimonate
Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3